NCT06147778 - Performances and Safety of MuCopilot, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

September 18, 2025

Study Completion Date

September 18, 2025

Conditions

Cystic Fibrosis

Interventions

DEVICE

MuCopilot mobile application

MuCopilot is a software as medical device with three digital tests, to measure patient's with CF, lung function, global exercise capacity and a questionnaire to address CF symptoms and impacts on some aspects of patient's life

Trial Locations (7)

13015

APHM - Hôpital Nord de Marseille, Marseille

29682

Centre de Perharidy, Fondation Idlys, Roscoff

31059

Hôpital Larrey, Toulouse

51100

American Memorial Hospital, Reims

69495

Centre Hospitalier Lyon Sud (Adultes), Lyon

76031

CRCM Mixte - Hôpital Charles Nicolle, Rouen

06002

Centre de compétence Maladies pulmonaires rares Hôpital Pasteur CHU de Nice, Nice